| Identification | Back Directory | [Name]
None | [CAS]
1083009-44-2 | [Synonyms]
5,5-difluoro-2,8-diiodo-1,3,7,9-tetramethyl-10-phenyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | [Molecular Formula]
C19H18BF2I2N2 | [MOL File]
1083009-44-2.mol | [Molecular Weight]
576.98 |
| Hazard Information | Back Directory | [Uses]
BDPI is the a BODIPY derivative. BDPI reveals a high O2 quantum yield and exhibits phototoxicity that inhibits HeLa with an IC50 of 0.6 μg/mL. BDPI nanoarticles can be taken up by HeLa, producing fluorescence signals in the cells, and can be used as cell imaging agent. BDPI nanoarticles exhibit antitumor efficacy in mouse models[1]. | [References]
[1] Zou J, et al., BODIPY Derivatives for Photodynamic Therapy: Influence of Configuration versus Heavy Atom Effect. ACS Appl Mater Interfaces. 2017 Sep 27;9(38):32475-32481. DOI:10.1021/acsami.7b07569 |
|
|